Purchase The RealStar SARS-CoV-2 RT-PCR Coronavirus Test Kit: Reliable and Affordable COVID Testing Solutions Starting from Rs. 120000!

2023-06-22 12:45:20 By : admin
Title: Altona RealStar SARS-CoV-2 RT-PCR Coronavirus Test Kit: An Effective PIV Diagnostic Test Kit

Introduction:
Altona RealStar SARS-CoV-2 RT-PCR Coronavirus Test Kit, Price from Rs.120000/unit onwards, specification and features

The Altona RealStar SARS-CoV-2 RT-PCR Coronavirus Test Kit has emerged as a highly reliable and efficient solution to detect the presence of the notorious COVID-19 virus. With its innovative PCR technology, this kit offers accurate results and helps in identifying individuals infected with the virus. In this blog post, we will delve into the specifications, features, and applications of this test kit while highlighting its competitive pricing and compatibility with various systems. Additionally, we will explore the significance of PIV diagnostic test kits in the fight against the global pandemic.

Specifications:
The Altona RealStar SARS-CoV-2 RT-PCR Coronavirus Test Kit is available in two variants - 384 Preps and 96 Preps, catering to the diverse needs of healthcare providers. The kit contains two Master Reagents (Master A & Master B), an Internal Control (IC), Positive Control, and PCR Grade Water. The use of these components ensures accuracy and reliability in the test results.

Features:
The RealStar SARS-CoV-2 RT-PCR Kit provides several features that contribute to its effectiveness in diagnosing COVID-19. The kit's compatibility with popularly used systems, such as Mx 3005P QPCR System, VERSANT kPCR Molecular System AD, and ABI Prism 7500 SDS, makes it adaptable for different laboratories and healthcare facilities. Furthermore, the kit is compatible with LightCycler 480 Instrument II, Rotor-Gene 6000, Rotor-Gene Q 5/6 plex Platfom, CFX96 Deep Well Real-Time PCR Detection System, CFX96 Deep Well Dx System, and CFX96 Real-Time PCR Detection System.

Applications:
The Altona RealStar SARS-CoV-2 RT-PCR Coronavirus Test Kit is a crucial tool in the battle against COVID-19. Its accurate results enable healthcare professionals to swiftly diagnose infected individuals and initiate appropriate measures to prevent the spread of the virus. The kit can be used in hospitals, diagnostic centers, research laboratories, and other medical facilities. Moreover, it aids authorities in monitoring the prevalence of the virus and making data-driven decisions to control the pandemic.

Competitive Pricing:
This test kit offers exceptional value for money, with prices starting from Rs.120,000 per unit. The reasonable pricing ensures wider accessibility for healthcare providers and facilitates large-scale testing efforts, which are essential in overcoming the challenges posed by the global pandemic.

The Significance of PIV Diagnostic Test Kits:
PIV diagnostic test kits, such as the Altona RealStar SARS-CoV-2 RT-PCR Coronavirus Test Kit, play a pivotal role in effectively managing the COVID-19 crisis. They provide the means to identify infected individuals accurately and promptly, allowing for timely isolation, treatment, and contact tracing. These test kits are vital tools in controlling the spread of the virus, protecting vulnerable populations, and aiding in the development of effective healthcare strategies.

Conclusion:
The Altona RealStar SARS-CoV-2 RT-PCR Coronavirus Test Kit has proven instrumental in the fight against COVID-19. With its reliable PCR technology, compatibility with various systems, and competitive pricing, this kit empowers healthcare providers and authorities in their efforts to contain the virus. Utilizing PIV diagnostic test kits is crucial to overcoming the challenges faced during a global pandemic, as they enable swift and accurate detection of infected individuals. By embracing these advanced testing solutions, we inch closer to restoring normalcy in our communities and safeguarding public health.

Keywords: PIV diagnostic test kit, Altona RealStar SARS-CoV-2 RT-PCR Coronavirus Test Kit, COVID-19, PCR technology, accurate results, compatibility, pricing, large-scale testing efforts, global pandemic, healthcare providers, virus detection, public health.